|  Join

Education

Welcome to the SMFM Podcast Series!

We launched the SMFM Podcast in February 2018 to highlight a range of topics that touch MFM. From congenital heart disease to mental illness, 3D ultrasound, preventing burnout and more, new episodes will released monthly. This series is available through iTunes and Google Play as well. Subscribe to the SMFM Podcast Series on your mobile device today! If you would like to submit a topic for consideration, leave a comment, or are interested in being a guest on our podcast series, please contact Chris Coleman at ccoleman@smfm.org.

Podcasts

  • Immediate postpartum LARC for women at high-risk for medical complications

    Contains 2 Component(s)

    Speaker: Dr. Laura Vricella
    Recorded: March 2019

    Join Dr. Vricella as she discusses immediate postpartum long-acting reversible contraceptives (LARC) which can help women prevent unplanned pregnancies and short interpregnancy intervals.

  • Sepsis

    Contains 2 Component(s)

    Speakers: Drs. Judette Louis and Tony Kendle
    Recorded: February 2019

    Maternal sepsis is a significant cause of maternal morbidity and mortality. Join Drs. Judette Louis and Tony Kendle as they discuss the Society for Maternal-Fetal Medicine’s new publication, “Sepsis During Pregnancy and the Puerperium.” In this podcast, they define sepsis and review the evaluation and management of sepsis in pregnancy and the postpartum period.

    To view the entire publication, click here

  • The impact of the HYPITAT I trial on obstetric management and outcomes for gestational hypertension and preeclampsia

    Contains 2 Component(s)

    Speaker: Dr. Catherine De Sonnaville
    Date recorded: January 2019

    Dr. De Sonnaville describes the HYPITAT 1 trial, highlighting the results showing the beneficial effects of induction of labor in pregnancies complicated by hypertensive disorders in term pregnancies. The recommendation of inducing patients with hypertensive disorders of pregnancy at term has been adopted by national guidelines. The study involved adult patients, singleton pregnancies in the cephalic presentation, at 36-41 weeks gestation. They had two cohorts – 1. Pregnancies complicated by hypertensive disorders – gestational hypertension or Preeclampsia and 2. Pregnancies not complicated by hypertensive disorders. The outcomes were onset of labor, maternal complications and neonatal complications. They compared the proportions of the period before the trial (2000-2005) to the period after the trial (2008-2014). They performed a subgroup analysis, compared the HYPITAT recruiting hospitals to the non-recruiting hospitals for the patients with hypertensive disorders.

  • Beneficios de pertenecer a la Sociedad de Medicina Materno-Fetal

    Contains 2 Component(s)

    ¡En español! ¿Conoces los beneficios de pertenecer a la Sociedad de Medicina Materno-Fetal? Escucha la charla entre el CEO de SMFM Matt Granato y el Dr. Jorge Tolosa, presidente del Comité de Salud Global de SMFM https://bit.ly/2STaiBK  

  • A Review of Hepatitis C in Pregnancy

    Contains 2 Component(s)

    Speaker: Dr. Brenna Hughes
    Recorded November 2018

    Join Dr. Brenna Hughes as she discusses the current evidence regarding hepatitis C virus in pregnancy. She reviews the epidemiology of hepatitis c in pregnancy, challenges of maternal infection on pregnancy and pregnancy outcomes, and screening/treatment/management recommendations of Hepatitis C during pregnancy.

  • Evaluating Cardiovascular Risk 10 years after Preeclampsia

    Contains 2 Component(s)

    Speaker: Dr. Lisa Levine
    Podcast Recorded: October 2018

    In this podcast Dr. Lisa Levine reviews her important research on the association between preeclampsia and cardiovascular disease. She reviews results from her study presented at SMFM 2018 where she discussed a cohort of women she evaluated for cardiovascular risk 10 years  after a pregnancy complicated by preeclampsia.

  • Feasibility of Complete Salpingectomy Compared With Standard Postpartum Tubal Ligation at Cesarean Delivery: A Randomized Controlled Trial

    Contains 2 Component(s)

    Speaker: Dr. Akila Subramaniam
    Podcast recording: September 2018

    Dr. Subramaniam discusses evaluating the feasibility of salpingectomy compared with standard bilateral tubal ligation at the time of cesarean delivery in women with undesired fertility.

  • Patient Safety and Quality Improvement for MFMs and High-Risk Patients

    Contains 2 Component(s)

    Speaker: Drs. Christian Pettker and Andrew Combs
    Recorded: August 2018

    SMFM’s Patient Safety & Quality Committee (PSQC) Chair Dr. Christian Pettker and Vice Chair Dr. Andrew Combs discuss the work of the PSQC and how SMFM members can get involved. 


  • Outcomes of Elective Inductions of Labor in Obese Women

    Contains 2 Component(s)

    Speaker: Dr. Anna Palatnik
    Podcast Recorded: August 2018

    This podcast provides a description of the retrospective cohort study performed by Dr. Palatnik and colleagues.

    Few studies have been performed to evaluate elective induction of labor in the obese population, however those that have been performed have conflicting results. Dr. Palatnik performed a retrospective cohort study from the Consortium on Safe Labor comparing obese women with a singleton gestation who underwent elective induction at >39 weeks versus expectant management.

    Their outcomes of interest includes cesarean section rate (primary outcomes), and adverse maternal and neonatal outcomes (including 3rd/4th degree laceration, postpartum hemorrhage, blood transfusion, endometritis, would infection, apgar score <7 at 5 minutes, macrosomia, presence of meconium, ICU admission and perinatal death at 39, 40 and 41 weeks), which were compared between the groups of elective induction and expectant management groups during the gestational age time frames – 39, 40, 41 weeks. Their statistical methods included univariable and multivariable analysis.

    They found that women undergoing induction of labor differed in several ways from the expectant management group – they were more likely to be older, white and married and had more favorable simplified bishops score. When reviewing the primary outcome, both nulliparous and multiparous women undergoing IOL were less likely to have cesarean. Macrosomia was also noted to be reduced in nulliparous and multiparous women undergoing induction of labor at 39 weeks.

    The authors concluded that in obese women, an elective induction of labor when compared to expectant management, was associated with decreased cesarean delivery rates and improved maternal and neonatal outcomes. They ended with saying further prospective studies will need to be performed to confirm these results.

     



  • Contraception for the High-Risk Obstetrical Patient: A Call to Action

    Contains 2 Component(s)

    Speakers: Drs. Judette Louis and Lara Vricella
    Recorded date: July 2018

    Contraception for the High-Risk Obstetrical Patient: A Call to Action

  • Mental Illness

    Contains 2 Component(s)

    Speaker: Dr. Rashimi Rao
    Podcast recorded: June 2018 

    Join Dr. Rao as she discusses what is “Mental Health”, and its impact on the mother, fetus and neonate. The podcast will also identify risk factors and how to screen for mental health disorders, and how to optimize care to women with a pre-existing diagnosis.

  • General Applications of 3D Imaging

    Contains 2 Component(s)

    Speaker: Dr. Dr. Chia-Ling Nhan-Chang
    Podcast recorded: May 2018

    Join MFM, Dr. Chia-Ling Nhan-Chang, as she provides a general overview on the role of 3D imaging in Perinatal ultrasound.

  • Getting Back Up: Being and Helping the Second Victim

    Contains 2 Component(s)

    Speakers: Drs. Heather Lipkind and Chris Pettker
    Podcast recorded: April 2018

    Adverse outcomes are rare in obstetrics but when they occur are devastating not only to patients but also the caregivers. Join Drs. Lipkind and Pettker for this 30-minute podcast as they use their personal experiences to discuss the resources for supporting 'second victim’ caregivers who experience critical events.  

  • Congenital Toxoplasmosis Prevention

    Contains 2 Component(s)

    Speaker: Dr. Laurent Mandelbrodt
    Podcast recorded: March 2018

    SMFM member, Dr. Laurent Mandelbrodt, discusses results from the TOXOGEST study, a randomized open-label trial comparing pyrimethamine/sulfadiazine to spiramycin in reduction of perinatal transmission of toxoplasma gondii.  The results were presented at the SMFM Annual Pregnancy Meeting in February 2018. 

  • Maternal Cardiovascular Disease

    Contains 2 Component(s)

    Speaker: Dr. Alexandria Hill
    Podcast was recorded: February 2018

    Join MFM Dr. Alexandria Hill as she speaks about cardiovascular disease in pregnant and postpartum woman. During this nine-minute podcast, Dr. Hill addresses the importance of identifying heart disease, considerations for MFM specialists caring for cardiac patients, and what national organizations are doing to address this growing problem.